Biden unveiling public database for clinical data on cancer WASHINGTON (AP) -- Vice President Joe Biden unveiled a public database for clinical data on cancer on Monday that aims to help researchers and doctors better tailor new treatments to individuals.
Mother of 3 takes on dead friend's 6 children When Beth Laitkep's breast cancer spread to her brain and spine, doctors knew she didn't have much time.
Novartis study shows skin cancer combo also works on lungs A Novartis trial of two drugs against an aggressive lung cancer bodes well for broadening their use beyond melanoma, the Swiss drugmaker told the American Society of Clinical Oncology's conference in Chicago on Tuesday.
Study finds cancer drug prices highest in U.S.; least affordable in India, China Americans pay the highest prices in the world for cancer drugs, but the treatments are least affordable in lower income countries, according to the results of a new study released on Monday.
AstraZeneca cuts costs and doubles down on cancer drugs AstraZeneca is to cut costs by $1 billion and increase its focus on cancer treatments after underlying earnings, hit by drug patent expiries, fell 12 percent in the first quarter, broadly in line with analyst expectations.
Combination drug therapies for cancer show promise at higher potential cost CHICAGO—Cancer researchers see promise in giving patients combinations of multiple drugs that are proving more effective than one or two.
Cancer treatment untested in many patients with immune problems The safety and effectiveness of a new cancer treatment known as immunotherapy is largely unknown in patients with autoimmune diseases, researchers say - and that might account for up to a quarter of individuals with lung cancer.
Cancer cell therapies could be approved next year: Juno, Kite Pharma A new wave of experimental cancer drugs that directly recruit the immune system's powerful T cells could begin reaching patients next year, according to companies presenting new data at the annual meeting of the American Society of Clinical Oncology.
Roche therapy helps 24 percent of untreated bladder cancer patients: study A newly approved immunotherapy from Roche Holding proved effective as an initial treatment for some patients with advanced bladder cancer, according to data presented on Sunday.
Mindfulness program may reduce fear, fatigue for cancer survivors A tailored six-week mindfulness program may lead to small improvements in some physical and psychological symptoms that breast cancer survivors often experience, according to a new study.
